ResMed Inc. Price Today
ResMed Inc.
RMD
Healthcare
$27.62B
💰
Market Cap
31.0
💸
Price to Earnings
$6.0
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
8 |
Strong Buy |
4 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
RMD Price Forecast Target
187.8 👉 227.0 +21%
RMD EPS Forecast
6.0 👉 8.1 +34%
Financials
Profit Margin
20 %
Revenue Growth
12.5 %
Dividend
$ 1.92
Held Percent
0.8% - Insiders
57.2% - Institutions
42.0% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Michael Burry Portfolio
Michael Burry, the renowned value investor and founder of Scion Asset Management, gained limited recognition until his story was documented in Michael Lewis' bestseller 'The Big Short.' Despite predicting the subprime mortgage crisis, Scion's AUM fe…
Daniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. …
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…📮FAQ
Some Frequently Asked Questions.
The ResMed Inc. industry is Medical Instruments & Supplies
The ResMed Inc. sector is Healthcare
The ResMed Inc. forecasted predicted Price to Earnings PE ratio is 23.1
The ResMed Inc. Price to Earnings PE ratio is 31.0
The Market Capitalization of ResMed Inc. is $27.62B
There are total of 145648888 float shares with 57.2% held by Institutions and 0.8% held by insiders
The MResMed Inc. forecasted Earnings per Share EPS is $8.1
The ResMed Inc. Earnings per Share EPS is 6.0
The ResMed Inc. company has $0 gross profits with 20 profit margins
The ResMed Inc. Earnings Growth is -0.072% with -0.072% quarterly earnings growth
The ResMed Inc. Revenue is $4504076800 with 0.125 revenue growth
The price target for ResMed Inc. stock is $227.0 for the high target and $164.0 for the low target
The consensus analyst recommendations for ResMed Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for ResMed Inc. is Buy, with the following breakdown:
- Buy: 8
- Strong Buy: 4
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of ResMed Inc. is 0.7
The dividend of ResMed Inc. is $1.92
The dividend yield of ResMed Inc. is 0.010199999%
The biggest institutional and mutual fund holders of ResMed Inc. stock are
The ResMed Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0